Overcoming Challenges in Gene Therapy Analytics - A Symposium You Can't Miss!

Now Available On-Demand!

Watch now and learn about three critical aspects of viral vector characterization:

• Charge Heterogeneity of Individual Capsid Proteins: Learn how charge heterogeneity of individual capsid proteins can be critical for the development of effective viral vector-based therapies.
• Standardizing Methods to Determine Full-to-Empty Ratios: Discover the latest techniques and best practices for accurately determining full-to-empty ratios, ensuring consistent and efficient gene therapy manufacturing.
• Characterizing vector purity using capillary electrophoresis (CE): Explore an automated CE-SDS method and gain insight into studying AAV sample impurities, including the detection of protein and encapsulated/free DNA, for gene therapy production.

Talks & Topics:

Extending the Development of iCIEF-Western Method from mAb to AAV to Support Extended Characterization
		Gangadhar Dhulipala Senior Scientist Regeneron

Landscape of Analytical Methods for the Characterization of AAV Full-to-Empty Particle
		Anthony Blaszyk, Ph.D. Senior Scientist I USP

		Ana Carreras González, Ph.D. QC Biochemistry Department Scientist Viralgen Vector Core Company

Moderator John Eugenis, Ph.D. Moderator ProteinSimple, a Bio-Techne Brand